Nucleic Acids Research, 1991, Vol. 19, No. 23 6547-6551
© 1991
MOLECULAR BIOLOGY |
Induction of the Cyp1a-1 dioxin-responsive enhancer in transgenic mice
1Howard Hughes Medical Institute One Baylor Plaza, Houston, TX 77030, USA 2Institute for Molecular Genetics Baylor College of Medicine One Baylor Plaza, Houston, TX 77030, USA
Received August 5, 1991. Revised October 28, 1991. Accepted October 28, 1991.
Cyp1a-1, whose product, aryl hydrocarbon hydroxylase, assists in detoxification of polycyclic aromatic hydrocarbons, is the best characterized of the murine cytochrome P450 genes. The Cyp1a-1 dioxinresponsive enhancer region has been previously analyzed in vitro and found to induce expression of heterologous genes upon exposure of transfected cells to various aromatic hydrocarbons. A 2.58 kbp DNA fragment containing the Cyp1a-1 enhancer elements and promoter region was coupled to the chloramphenicol acetyltransferase (CAT) reporter gene and used to create transgenic mice. CAT assays were performed on tissues harvested from three different lines of transgenic mice following mock-induction or induction using the aromatic hydrocarbon, 3-methylcholanthrene. Basal levels of expression were detected in the spleen and small bowel of non-induced mice, with little or no expression detected in the liver. Treatment with 3-methylcholanthrene increased hepatic expression levels by as much as 10,000-fold. More modest levels of induction were also recorded in the spleen, small bowel, kidney, and lung. The results indicate that the dioxin-responsive enhancer region functions as a strongly inducible promoter in vivo. Differences in the response to induction between male and female mice suggest that Cyp1a-1 expression may be governed in a gender related manner.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. La Merrill, D. S. Baston, M. S. Denison, L. S. Birnbaum, D. Pomp, and D. W. Threadgill Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E203 - E210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Galijatovic, D. Beaton, N. Nguyen, S. Chen, J. Bonzo, R. Johnson, S. Maeda, M. Karin, F. P. Guengerich, and R. H. Tukey The Human CYP1A1 Gene Is Regulated in a Developmental and Tissue-specific Fashion in Transgenic Mice J. Biol. Chem., June 4, 2004; 279(23): 23969 - 23976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Henderson and C. R. Wolf Transgenic Analysis of Human Drug-Metabolizing Enzymes: Preclinical Drug Development and Toxicology Mol. Interv., September 1, 2003; 3(6): 331 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Narumi, M. Suzuki, W. Song, M. A.S. Moore, and R. G. Crystal Intermittent, Repetitive Corticosteroid-Induced Upregulation of Platelet Levels After Adenovirus-Mediated Transfer to the Liver of a Chimeric Glucocorticoid-Responsive Promoter Controlling the Thrombopoietin cDNA Blood, August 1, 1998; 92(3): 822 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Campbell, F Carlotti, P. Hall, A. Clark, and C. Wolf Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation J. Cell Sci., January 11, 1996; 109(11): 2619 - 2625. [Abstract] [PDF] |
||||




